Christopher James Frankenfield's Net Worth
$0
Who is Christopher James Frankenfield?
Christopher James Frankenfield does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Xilio Therapeutics, Inc..
SEC CIK
Christopher James Frankenfield's CIK is 0001988344
Past Insider Trading and Trends
2023 was Christopher James Frankenfield's most active year for acquiring shares with 2 total transactions. Christopher James Frankenfield's most active month to acquire stocks was the month of July. 2023 saw Christopher James Frankenfield paying a total of $0.00 for 450,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
CHIEF OPERATING OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||